We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVNI:NASDAQNvni Group Limited Analysis

Data as of 2026-04-21 - not real-time

$1.31

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nvni Group Limited is trading well beneath its short‑term moving averages, signaling a bearish technical backdrop despite a modestly bullish MACD histogram and a neutral‑ish RSI. The price sits near a key support level while the 200‑day trend remains down, and volume has been tapering, underscoring weakening momentum. Fundamentally, the company is reporting negative earnings, a negative price‑to‑earnings multiple, and a book value per share that is below zero, indicating significant profitability challenges. The balance sheet shows a sizable debt load relative to cash, and cash flow from operations is negative, raising concerns about cash sustainability. Volatility is exceptionally high and beta exceeds the market, pointing to amplified price swings. Recent news of a major acquisition of a majority stake in Beyondsoft’s U.S. business adds a strategic growth narrative but also introduces execution risk. The market’s sentiment is in “Extreme Greed” mode, yet the stock’s current price is a fraction of its 52‑week high, suggesting a large upside potential if the acquisition delivers synergies. Liquidity is constrained with a low average daily volume and a decreasing volume trend, which could exacerbate price moves. Overall, the stock presents a paradox of high risk and potential reward, demanding careful timing and risk management.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below short‑term moving averages
  • decreasing volume trend
  • negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • integration risk of the Beyondsoft acquisition
  • potential improvement in revenue growth
  • still elevated volatility and beta

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • significant upside relative to current price
  • strategic expansion through acquisition
  • potential turnaround if profitability improves

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin-53.75%
P/E Ratio-6.5
P/B Ratio-0.6
Op. Cash Flow$-11029000
Industry P/E37.0

Technical Analysis

TrendBearish
RSI51.2
Support$0.96
Resistance$1.68
MA 20$1.23
MA 50$1.32
MA 200$3.65
MACDBullish
VolumeDecreasing
Fear & Greed Index87.3

Valuation

Target Price$8.00
Upside/Downside510.69%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.37
Volatility151.75%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.